1NKEMIA Logo

1NKEMIA

Biotechnology company providing R&D and services for the life sciences sector.

IKM | BME Growth

Overview

Corporate Details

ISIN(s):
ES0156303002
LEI:
959800QRRHKJ6C8MW495
Country:
Spain
Address:
C/Alvarez de Castro 63, 08100 Mollet del Vallès

Description

1NKEMIA is a biotechnology company focused on generating high-value technological knowledge for the life sciences sector. The company's activities are structured around four main areas: Open R&D and innovation, technological services, specialized training, and the management of a knowledge capital fund. It provides services such as analytical development and validation to a diverse client base in the chemical, pharmaceutical, biotechnological, cosmetic, and nutraceutical industries. Operating as a group, 1NKEMIA also holds interests in various specialized companies to foster technological advancement and collaboration within its target markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all 1NKEMIA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 1NKEMIA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 1NKEMIA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-27 Peter Sandberg Other Sell 1,000 98,500.00 SEK
2025-02-26 Nicklas Johansson Other Other 30,000 30,000.00 SEK
2025-02-26 Tord Nils Gunnar Ringenhall Other Buy 30,000 30,000.00 SEK
2025-02-26 Nicklas Johansson Other Other 10,000 10,000.00 SEK
2025-02-26 Henrik Hemark Other Buy 10,000 10,000.00 SEK
2025-02-26 Lars Thorsson Other Other 30,000 N/A
2025-02-25 Charlotte Brogren Karlberg Other Buy 40,000 100,000.00 SEK
2025-02-24 Peter Sandberg Other Buy 25,000 52,500.00 SEK
2025-02-24 Peter Sandberg Other Buy 13,494 28,607.28 SEK
2025-02-21 Peter Sandberg Other Sell 3,000 285,000.00 SEK

Peer Companies

2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG
Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.